Found 0 matching trials
Potential Efficacy and Safety of Using Adjunctive Ibuprofen for XDR-TB Tuberculosis PHASE2 Novel approaches to improve TB treatment outcomes (to reduce morbidity, mor...
Show More Location
National Center for Tuberculosis and Lung Diseases
Learn More & Join Trial
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI) PHASE2 This research study is designed to evaluate the safety, tolerability, and e...
Show More Location
UCLA Stroke Network
Learn More & Join Trial
Proof-of-concept Study Evaluating Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Hidradenitis Suppurativa PHASE2 This is a parallel, Phase 2, 2-arm, double-blind, randomized, multicenter, ...
Show More Location
Medical Dermatology Specialists Site Number : 8400002
Learn More & Join Trial
A Phase 1 Study of PROT-001. PHASE1 A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Show More Location
Nucleus Network Pty Ltd
Learn More & Join Trial
BI 443651 Methacholine Challenge PHASE1 The primary objective of this study is to investigate safety and tolerabili...
Show More Location
The Medicines Evaluation Unit
Learn More & Join Trial
Bacillus Subtilis and Enterococcus Faecium Probiotic Plus Lipid-Lowering Therapy for Hypertriglyceridemic Acute Pancreatitis: A Prospective RCT PHASE4 Background: Hypertriglyceridemia-associated acute pancreatitis (HTG-AP) has...
Show More Location
Department of Gastroenterology, Zhongshan Hospital, Xiamen University
Learn More & Join Trial
Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059) PHASE1 A clinical study to determine the safety, efficacy and the way sitagliptin ...
Show More Location
Multiple Locations
Learn More & Join Trial
Behavioral and Subjective Efficacy of Ramelteon in Subjects With a History of Polydrug Abuse PHASE2 The purpose of this study is to determine the relative abuse potential of r...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis PHASE2 This is a dose-ranging study designed to investigate the efficacy and safet...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial
Influence of Genotype of CYP2C9 on Clinical Efficacy and Pharmacokinetics of Piroxicam After Lower Third Molar Surgery PHASE4 Pharmacogenetics is an area of Pharmacology that studies the contribution o...
Show More Location
Multiple Locations
Learn More & Join Trial